Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication for Unaudited Financial Results (Standalone & Consolidated) for quarter ended June 30, 2023 - Regulation 30 and 47 of SEBI LODR21-07-2023
21-07-2023
Shalby Ltd - 540797 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for FY 2022-2321-07-2023
Shalby Ltd - 540797 - Reg. 34 (1) Annual Report.
Annual Report for financial year 2022-2321-07-2023
Q1FY24 Quarterly Result Announced for Shalby Ltd.
Healthcare Facilities company Shalby announced Q1FY24 results: Consolidated Q1FY24: Revenues of Rs 2,400 million, growth of 15% QoQ and 17% YoY EBITDA of Rs 477 million, growth of 37% QoQ and 8% YoY PBT of Rs 330 million, growth of 72% QoQ and 8% YoY Basic EPS of Rs 1.94 during the quarter, growth of 50% QoQ Standalone Q1FY24: Revenues of Rs 2,164 million, growth of 18% QoQ and 20% YoY EBITDA of Rs 497 million, growth of 36% QoQ and 16% YoY PBT of Rs 400 million, growth of 51% QoQ and 22% YoY EBITDA margin of 23% in Q1FY24 v/s 20% in Q4FY23 and 23.6% in Q1FY23 In-patient count (incl. Day Care) of 20,661, growth of 11% QoQ and 24% YoY Total Surgery count of 8,183, growth of 25% QoQ and 14% YoY Occupancy rate at 50% in Q1FY24 v/s 46% in Q4FY23 and 45% in Q1FY23 ARPOB during the quarter was 38,000, a growth of 9% QoQ and 8% YoY Shanay Shah, President, Shalby, said: “I am very happy to report that this quarter reflected our best hospital business performance so far, across most financial and operating parameters, recording significant growth year-on-year and quarter-on-quarter. I am also proud to say that Shalby has achieved a landmark of 150,000 joint replacement surgeries (since inception) in Q1FY24 and with this we continue to maintain the leadership position in global volumes in the Orthopedics segment. Our hospital business continued to grow high double-digit in the key metrics of In-Patient counts and surgery counts, growing by 24% and 14% respectively YoY in Q1FY24. Our hospital occupancy levels improved by 12% YoY and 8% QoQ and recorded a 50% occupancy rate in Q1FY24. ARPOB and ALOS were recorded at Rs 38,000 and 3.97 respectively in Q1FY24 vis-à-vis Rs 35,304 and 4.08 in the same quarter of the previous year. Hospital revenue and EBITDA also grew by 18% and 36% QoQ respectively and 20% and 16% YoY respectively with a robust EBITDA margin of 23% in Q1FY24 v/s 20% in Q4 FY23. Our core specialties like Arthroplasty, Oncology, Cardiac Science, Orthopedic, Critical care & General Medicine, and Neurology contributed 85% to the revenues in Q1FY24. Our Homecare business demonstrated a strong performance in Q1FY24, growing by 70% YoY and 30% QoQ. International revenue continued to grow in Q1FY24 from Q1FY23 whereby the majority of the patients came from East African countries. Shalby also takes pride in nurturing young talent through our Shalby Academy vertical with 290+ students registered in the various healthcare programs during Q1FY24. Realized Return on Capital Employed from hospital business recorded at 20% in Q1FY24 on an annualized basis. We have closed the quarter with a net cash balance of Rs 806 million at the group level and are well-positioned to fund our strategic growth plans. Shalby continued to add many milestones backed by clinical excellence and patient care. We remain committed to making a positive difference in people's lives." Result PDF20-07-2023
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on financial and operational performance for quarter ended June 30, 202320-07-2023
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for Unaudited Financial Results for quarter ended June 30, 202320-07-2023
Shalby Ltd - 540797 - Board Meeting Outcome for Outcome Of Board Meeting For Unaudited Financial Results For Quarter Ended June 30, 2023
Outcome of Board Meeting for unaudited Financial Results for Quarter ended June 30, 202320-07-2023
Shalby Ltd - 540797 - Financial Results For Quarter Ended June 30, 2023
Financial Results for quarter ended June 30, 202320-07-2023
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor Conference call to discussed Q1 FY 2024 Financial results17-07-2023